Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Journal article

Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5

Joint statement in support of hepatitis C human challenge studies.

Journal article

Alter HJ. et al, (2023), The lancet. Gastroenterology & hepatology

An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome

Journal article

Ng E. et al, (2023), Journal of General Virology, 104

Defining the key intrahepatic gene networks in HCV infection driven by sex

Journal article

Marchi E. et al, (2023), Gut, 72, 984 - 994

Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.

Journal article

Hamill V. et al, (2023), Liver international : official journal of the International Association for the Study of the Liver, 43, 917 - 927

Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses

Journal article

Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults

Journal article

Green C. et al, (2023), Clinical and Experimental Immunology, 211, 269 - 279

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Journal article

Brevini T. et al, (2023), Nature, 615, 134 - 142

Load More